Brotman Hospital Inpatient Pharmacy is categorized under Hospitals in Culver City, CA and active since 2001.
Brotman Hospital Inpatient Pharmacy was established in 2001, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Hospitals business, which does work in the B2C market, and is classified as a Hospitals, under code number 622110 by the NAICS.
If you are seeking more information, feel free to contact Luana Murphy at the company’s single location by writing to 3828 Delmas Terrace, Culver City, California CA 90232 or by phoning (310) 202-4706. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Brotman Hospital Inpatient Pharmacy |
| Contact Person: | Luana Murphy |
| Address: | 3828 Delmas Terrace, Culver City, California 90232 |
| Phone Number: | (310) 202-4706 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Hospitals |
| SIC Code: | 8062 |
| NAICS Code: | 622110 |
| Share This Business: |
Brotman Hospital Inpatient Pharmacy was started in 2001 to provide professional Hospitals under the SIC code 8062 and NAICS code 622110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Luana Murphy for inquiries that concern Brotman Hospital Inpatient Pharmacy by calling the company number (310) 202-4706, as your correspondence is most welcome. Additionally, the physical location of the single location of Brotman Hospital Inpatient Pharmacy can be found at the coordinates 34.023369,-118.397266 as well as the street address 3828 Delmas Terrace in Culver City, California 90232.
For its online presence, you may visit Brotman Hospital Inpatient Pharmacy’s website at and engage with its social media outlets through on Twitter and on Facebook.